[(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate

C45H77N3O18P2 — CID 157001722

IUPAC[(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate
SMILESCCCCC[C@@H](O)/C=C/[C@@H]1[C@H](O)[C@H](O)[C@H]2COP(=O)(O)OP(=O)(O)OC[C@H](OC(=O)CCCCCCCCCCCC(C)C)COC(=O)C/C=C\C[C@@H]([C@H](n3ccc(N)nc3=O)O2)[C@@H](O)C[C@H]1O
InChIInChI=1S/C45H77N3O18P2/c1-4-5-13-19-32(49)23-24-34-36(50)27-37(51)35-20-16-17-21-40(52)61-28-33(64-41(53)22-15-12-10-8-6-7-9-11-14-18-31(2)3)29-62-67(57,58)66-68(59,60)63-30-38(43(55)42(34)54)65-44(35)48-26-25-39(46)47-45(48)56/h16-17,23-26,31-38,42-44,49-51,54-55H,4-15,18-22,27-30H2,1-3H3,(H,57,58)(H,59,60)(H2,46,47,56)/b17-16-,24-23+/t32-,33-,34+,35-,36-,37+,38-,42+,43-,44-/m1/s1
InChIKeyVPYTVDCADXIVEB-UTBCEXTHSA-N
MW1010.06 g/mol
LogP5.29
Rot. Bonds20

About [(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate

[(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate (PubChem CID 157001722) has the molecular formula C45H77N3O18P2 and a molecular weight of 1010.06 g/mol. Its IUPAC name is [(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate.

Molecular Properties

Compound Name[(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate
PubChem CID157001722
Molecular FormulaC45H77N3O18P2
Molecular Weight1010.06 g/mol
Exact Mass1009.47
IUPAC Name[(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate
SMILESCCCCC[C@@H](O)/C=C/[C@@H]1[C@H](O)[C@H](O)[C@H]2COP(=O)(O)OP(=O)(O)OC[C@H](OC(=O)CCCCCCCCCCCC(C)C)COC(=O)C/C=C\C[C@@H]([C@H](n3ccc(N)nc3=O)O2)[C@@H](O)C[C@H]1O
InChIInChI=1S/C45H77N3O18P2/c1-4-5-13-19-32(49)23-24-34-36(50)27-37(51)35-20-16-17-21-40(52)61-28-33(64-41(53)22-15-12-10-8-6-7-9-11-14-18-31(2)3)29-62-67(57,58)66-68(59,60)63-30-38(43(55)42(34)54)65-44(35)48-26-25-39(46)47-45(48)56/h16-17,23-26,31-38,42-44,49-51,54-55H,4-15,18-22,27-30H2,1-3H3,(H,57,58)(H,59,60)(H2,46,47,56)/b17-16-,24-23+/t32-,33-,34+,35-,36-,37+,38-,42+,43-,44-/m1/s1
InChIKeyVPYTVDCADXIVEB-UTBCEXTHSA-N
XLogP5.29
TPSA326.18 Ų
H-Bond Donors8
H-Bond Acceptors19
Rotatable Bonds20
Heavy Atoms68
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001010.06
LogP ≤ 55.29
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate?
The IUPAC name of [(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate (CID 157001722) is [(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate.
What is the SMILES notation for [(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate?
The canonical SMILES for [(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate is CCCCC[C@@H](O)/C=C/[C@@H]1[C@H](O)[C@H](O)[C@H]2COP(=O)(O)OP(=O)(O)OC[C@H](OC(=O)CCCCCCCCCCCC(C)C)COC(=O)C/C=C\C[C@@H]([C@H](n3ccc(N)nc3=O)O2)[C@@H](O)C[C@H]1O.
What is the InChIKey of [(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate?
The InChIKey is VPYTVDCADXIVEB-UTBCEXTHSA-N. The full InChI is InChI=1S/C45H77N3O18P2/c1-4-5-13-19-32(49)23-24-34-36(50)27-37(51)35-20-16-17-21-40(52)61-28-33(64-41(53)22-15-12-10-8-6-7-9-11-14-18-31(2)3)29-62-67(57,58)66-68(59,60)63-30-38(43(55)42(34)54)65-44(35)48-26-25-39(46)47-45(48)56/h16-17,23-26,31-38,42-44,49-51,54-55H,4-15,18-22,27-30H2,1-3H3,(H,57,58)(H,59,60)(H2,46,47,56)/b17-16-,24-23+/t32-,33-,34+,35-,36-,37+,38-,42+,43-,44-/m1/s1.
What are the key properties of [(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate?
[(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate has a molecular weight of 1010.06 g/mol, XLogP of 5.29, 20 rotatable bonds, 8 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,9R,14Z,17R,18S,20R,21S,22S,23S,25R)-25-(4-amino-2-oxopyrimidin-1-yl)-4,6,18,20,22,23-hexahydroxy-21-[(E,3R)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,24-pentaoxa-4λ5,6λ5-diphosphabicyclo[15.6.2]pentacos-14-en-9-yl] 13-methyltetradecanoate is sourced from PubChem (CID 157001722), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).